Literature DB >> 14966050

Relation between left ventricular contractile reserve during low dose dobutamine echocardiography and plasma concentrations of natriuretic peptides.

A F L Schinkel1, E C Vourvouri, J J Bax, F Boomsma, M Bountioukos, V Rizzello, E Biagini, E Agricola, A Elhendy, J R T C Roelandt, D Poldermans.   

Abstract

BACKGROUND: In ischaemic cardiomyopathy, raised plasma concentrations of natriuretic peptides are associated with a poor long term prognosis, while the presence of contractile reserve is a favourable sign.
OBJECTIVE: To assess the relation between plasma natriuretic peptides and contractile reserve.
DESIGN: Prospective observational study.
SETTING: Tertiary referral centre. PATIENTS: 66 consecutive patients undergoing low dose dobutamine stress echocardiography to evaluate contractile reserve in regions with contractile dysfunction at rest, divided into two groups: group 1, 31 patients with ischaemic cardiomyopathy (left ventricular ejection fraction < or = 40%) and heart failure symptoms; group 2, 35 patients with normal left ventricular function. MAIN OUTCOME MEASURES: Plasma atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), measured using immunoradiometric assays. Contractile reserve was defined as an improvement in segmental wall motion score during infusion of low dose dobutamine.
RESULTS: Plasma ANP and BNP concentrations were higher in group 1 than in group 2 (mean (SD): ANP, 17.8 (32.8) v 7.2 (9.7), p < 0.005; BNP, 24.4 (69.0) v 5.0 (14.3) pmol/l, respectively; p < 0.001). In group 1, the presence of contractile reserve was inversely related to ANP and BNP levels; however, patients with contractile reserve had lower ANP and BNP concentrations than patients without contractile reserve (ANP, 14.2 (9.1) v 24.2 (44.2), p < 0.05; BNP, 20.2 (25.5) v 37.5 (93.8) pmol/l, respectively; p < 0.05).
CONCLUSIONS: Plasma natriuretic peptide concentrations are raised in patients with left ventricular dysfunction, but in the presence of preserved myocardial contractile reserve, relatively low levels of ANP and BNP are present.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966050      PMCID: PMC1768093          DOI: 10.1136/hrt.2002.003822

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

Review 1.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

2.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.

Authors:  Peter A McCullough; Edward F Philbin; John A Spertus; Scott Kaatz; Keisha R Sandberg; W Douglas Weaver
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

3.  Regional wall motion index for infarct and noninfarct regions after reperfusion in acute myocardial infarction: comparison with global wall motion index.

Authors:  P D Bourdillon; T M Broderick; S G Sawada; W F Armstrong; T Ryan; J C Dillon; N S Fineberg; H Feigenbaum
Journal:  J Am Soc Echocardiogr       Date:  1989 Nov-Dec       Impact factor: 5.251

4.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

Authors:  T A McDonagh; A D Cunningham; C E Morrison; J J McMurray; I Ford; J J Morton; H J Dargie
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

5.  Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  J A Panza; V Dilsizian; R V Curiel; E F Unger; J M Laurienzo; A N Kitsiou
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

Review 6.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

7.  Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.

Authors:  M Nakamura; H Endo; M Nasu; N Arakawa; T Segawa; K Hiramori
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

8.  Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk.

Authors:  O W Nielsen; J Hilden; C T Larsen; J F Hansen
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

9.  B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.

Authors:  Peter A McCullough; Richard M Nowak; James McCord; Judd E Hollander; Howard C Herrmann; Philippe G Steg; Philippe Duc; Arne Westheim; Torbjørn Omland; Cathrine Wold Knudsen; Alan B Storrow; William T Abraham; Sumant Lamba; Alan H B Wu; Alberto Perez; Paul Clopton; Padma Krishnaswamy; Radmila Kazanegra; Alan S Maisel
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

10.  Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings.

Authors:  A Maes; W Flameng; J Nuyts; M Borgers; B Shivalkar; J Ausma; G Bormans; C Schiepers; M De Roo; L Mortelmans
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

View more
  1 in total

1.  Hibernating myocardium: high or low risk?

Authors:  J H McGowan
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.